Experience

Pfenex Inc. v. GlaxoSmithKline Biologicals SA

Pfenex Inc.

GlaxoSmithKline Biologicals SA

Representing patent owner GlaxoSmithKline Biologicals SA in multiple inter partes review (IPR) proceedings involving vaccine production patents.

Pfenex Inc. v. GlaxoSmithKline Biologicals SA, IPR2019-01027, -01028, PTAB

Related Professionals

Richard B. Racine
Senior Counsel
Washington, DC
+1 202 408 4038
Email
Amanda K. Murphy, Ph.D.
Partner
London
+44 (0)20 7864 2814
Email
Yieyie Yang, Ph.D.
Partner
Washington, DC
+1 202 216 5170
Email

Related Practices

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Industries

Life Sciences

Biologics

Related Experiences

Merck Sharp & Dohme Corp. v. GlaxoSmithKline Biologicals SA

GlaxoSmithKline Biologicals SA

Danisco US Inc. v. Novozymes A/S

Danisco US Inc.

Sandoz, Inc. et al v. Pharmacyclics LLC

Pharmacyclics LLC; Janssen Biotech, Inc.

ClearOne, Inc. v. Shure Acquisition Holdings, Inc.

Shure Acquisition Holdings, Inc.

Auris Health, Inc. v. Intuitive Surgical Operations

Intuitive Surgical Operations

William Hill U.S. Holdco, Inc. v. CG Technology Development, LLC

CG Technology Development, LLC

Google LLC v. SpeakWare, Inc.

Google LLC

NetApp, Inc./HPE et al. v. KOM Software Inc.

NetApp, Inc/HPE et al.

Georgetown Rail Equipment Company v. Tetra Tech Canada, Inc.

Tetra Tech Canada, Inc.

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.